Publications
- Prevention and treatment of osteoporosis in postmenopausal women with estrogen receptor-positive breast cancer receiving aromatase inhibitors2018 | First Faculty of Medicine
- Comparison of the effect of teriparatide and risedronate on bone loss in postmenopausal women with multiple sclerosis treated with low-dose glucocorticoids2015 | First Faculty of Medicine
- Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment2014 | First Faculty of Medicine
- Adipose tissue and the skeleton - new insights into the pathogenesis of osteoporosis2013 | First Faculty of Medicine
- Bone Mineral Density and Body Composition in Men With Multiple Sclerosis Chronically Treated With Low-Dose Glucocorticoids2012 | Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis2012 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- New perspectives of the treatment of osteoporosis2012 | First Faculty of Medicine
- Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis2012 | First Faculty of Medicine
- Limited walking ability significantly contributes to a loss of bone mineral density in the proximal femur in premenopausal and postmenopausal women with multiple sclerosis2012 | First Faculty of Medicine
- Bone Mineral Density and Body Composition in Men With Multiple Sclerosis Chronically Treated With Low-Dose Glucocorticoids2012 | First Faculty of Medicine
Loading network view...